'No find­ing of re­search mis­con­duc­t': MIT ends 3.5-year re­view of biotech founder, pro­fes­sor Sasisekha­ran

The Mass­a­chu­setts In­sti­tute of Tech­nol­o­gy said it found no re­search mis­con­duct af­ter al­le­ga­tions were levied against bi­o­log­i­cal en­gi­neer­ing pro­fes­sor and re­peat biotech founder Ram Sasisekha­ran.

In 2019, founders of famed an­ti­body dis­cov­ery com­pa­ny Adimab went to the jour­nal mAbs and claimed that two an­ti­body ther­a­pies de­scribed by Sasisekha­ran’s lab had “strik­ing sim­i­lar­i­ties” to work of pre­vi­ous sci­en­tists. The al­le­ga­tions were made by Till­man Gern­gross, Adimab’s CEO, and his col­leagues, in­clud­ing MIT pro­fes­sor Dane Wit­trup.

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

SIGN UP LOG IN